Dexamethasone, a corticosteroid, has become common for the treatment of COVID-19. Corticosteroids can cause hyperglycemia in patients with and without diabetes. Corticosteroid-induced hyperglycemia can be challenging but necessary to treat for the body to heal properly and to prevent further complications. A glycemic management team like GlyCare can help control blood glucose levels for these patients.

Doctors are currently speculating about when the second wave of COVID-19 will arrive. As we now well know, people with chronic diseases are at a greater risk of complications from COVID-19. Proper management of chronic diseases and keeping them at bay are key to minimizing the devastating effects of COVID-19. Diabetes is one such chronic disease that needs to be managed properly.

People who live in rural areas are more likely than urban residents to have higher rates of unhealthy behaviors and less access to healthy foods and health care. Rural populations also have higher rates of diabetes which we all know leads to higher rates and greater severity of heart disease and stroke among other complications. GlyCare can help reduce the shortage of medical specialties in rural areas with specialized diabetes care via virtual health.

Hospital censuses have currently taken an overall hit on non-COVID-19 patients. While not officially predicted, it only makes sense that the censuses will experience a dramatic increase once the coronavirus pandemic begins to settle down. Proactive planning is key to reducing morbidity, mortality, and other undesirable effects. Glycemic management teams like GlyCare can help reduce anticipated burdens on hospital physicians.

The United States currently has the most confirmed cases of COVID-19 (CDC, 2020). People with underlying health conditions such as diabetes are at a higher risk of experiencing serious complications from COVID-19 (NCIRD, 2020). Diabetes management groups, such as GlyCare, can help avoid or lessen such complications by managing the blood sugars of patients with diabetes.